Atomoksetin ile İlişkili Motor Tikler: Bir Olgu Sunumu

Dikkat Eksikliği ve Hiperaktivite Bozukluğu (DEHB) tanılı olgular Tourette Sendromu ve diğer tik bozuklukları için artmış riske sahiptirler. Metilfenidat gibi psikostimulanlar DEHBnin tedavisinde temel tedaviyi teşkil etmektedir. Psikostimulan ilaçların var olan tiklerde artışa ya da yeni tik oluşumuna neden olabileceği bilinmektedir. Özgül bir norepinefrin geri alım inhibitörü olan atomoksetinin, DEHB ile birlikte tik bozukluğu olan olgularda alternatif bir tedavi seçeneği olabileceği ileri sürülmektedir. Ancak literatürde atomoksetin tedavisi ile birlikte yeni tik oluşumu olan yamevcut tiklerin sıklığında artış bulunan olgu sunumları mevcuttur. Bu yazıda atomoksetin tedavisi ile motor tik oluşumu gözlenen bir olgu tartışılmıştır. da

Motor Tics Associated with Atomoxetine: A Case Report

Motor Tics Associated with Atomoxetine: A Case Report Patients with attention deficit and hyperactivity disorder (ADHD) are at increased risk for Tourettes Disorder and other tic disorders. The cornerstone treatment for ADHD include the psychostimulants, such as methylphenidate. It is known that, psychostimulant use can increase existing tics or cause new tics. The selective norepinephrine reuptake inhibitor, atomoxetine, has been proposed to be an alternative medication for patients with ADHD and a comorbid tic disorder. However, there are case studies in the literature describing onset or increase of tics following treatment with atomoxetine. In this report, we discuss a clinical case that developed motor tics during atomoxetine treatment .

PDF

___

KAYNAKLAR 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. Polanczyk G, Jensen P. Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update. Child Adolesc Psychiatr Clin N Am 2008; 17: 245-60. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry 1999; 56: 1073-86. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, (DSM- IV-TR). Washington (DC): American Psychiatric Association, 2000. Denckla MB, Bemporad JR, MacKay MC. Tics following methylphenidate administration A report of 20 cases. JAMA 1976; 235: 1349-51. Lipkin PH, Goldstein IJ, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention- deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 1994; 148: 859-61. Tourettes Syndrome Study Group. Treatment of ADHD in children with tics: A randomized, controlled trial. Neurology 2002; 58: 527-36. Law SF, Schachar RJ. Do typical clinical doses of methylphenidate cause tics in children treated for attention- deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 1999; 38: 944-51. Zhou J. Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future 2004; 29: 1235-44. Allen AJ, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorder. Neurology 2005; 65: 1941-9. Spencer TJ, Sallee FR, Gilbert DL, et al. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord 2008; 11: 470-81. Pringsheim T, Steeves T. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev 2011; CD007990. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 2009; 48: 884-93. Lewis D, Linder S, Kurlan R, et al. Atomoxetine for the treatment of attention deficit hyperactivity disorder and comorbid tics in children. Ann Neurol 2003; 54: 106. Ledbetter M. Atomoxetine use associated with onset of a motor tic. J Child Adolesc Psychopharmacol 2005; 15: 331-3. Párraga HC, Párraga MI, Harris DK. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder. Int J Psychiatry Med 2007; 37: 415-24. Sears J, Patel NC. Development of tics in a thirteen-year-old male following atomoxetine use. CNS Spectr 2008; 13: 301-3. Küçükköse M, Özbaran NB, Köse SG. Atomoksetin kullanımına bağlı motor tikler: olgu sunumu. Klinik Psikofarmakoloji Bülteni 2011; 21: 364-7. Leckman JF, Riddle MA, Hardin MT, et al. The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28: 566-73. Zaimoğlu S, Arman A, Sabuncuoğlu O. Yale genel tik ağırlığının derecelendirme ölçeği güvenirlik çalışması. 5.Ulusal Çocuk ve Ergen Psikiyatrisi Kongresi, Ankara, 1995. Sadock BJ, Sadock VA. Kaplan&Sadocks synopsis of psychiatry. 10th edition, Philadelphia: Lippincott Williams & Wilkins, 2007: 1235-44. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of gilles de la Tourettes syndrome. Arch Gen Psychiatry 1991; 48: 324-8. Turgay A. Psikostimülanlar. Çocuk ve ergen psikiyatrisi temel kitabı içinde, F. Çuhadaroğlu ve ark (eds). Ankara: Hekimler Yayın Birliği, 2008: 647-52.